Integra LifeSciences (IART) Reports In-Line Q2 EPS, Revenues Miss; Boosts FY18 EPS/Revenue Mid-Point Outlooks Below Consensus
Go back to Integra LifeSciences (IART) Reports In-Line Q2 EPS, Revenues Miss; Boosts FY18 EPS/Revenue Mid-Point Outlooks Below Consensus| Integra LifeSciences Holdings (NASDAQ: IART) | Delayed: 17.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.60 | 52 Week High | $88.86 | |||
| Open | $17.60 | 52 Week Low | $54.75 | |||
| Day High | $17.60 | P/E | N/A | |||
| Day Low | $17.60 | EPS | $-0.59 | |||
| Volume | 79 | |||||
